Cargando…
BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management
BRIC nations – Brazil, Russia, India, and China – represent 40% of the world’s population, including a growing aging population and middle class with an increasing prevalence of chronic disease. Their healthcare systems increasingly rely on prescription drugs, but they differ from most other healthc...
Autores principales: | Rodwin, Victor G., Fabre, Guilhem, Ayoub, Rafael F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890064/ https://www.ncbi.nlm.nih.gov/pubmed/29524948 |
Ejemplares similares
-
Meeting the Challenge of Diabetes in China
por: Luo, Zhen, et al.
Publicado: (2019) -
Public health and medical care for the world's factory: China's Pearl River Delta Region
por: Fabre, Guilhem, et al.
Publicado: (2011) -
BigPharma and unethical marketing of medicinal products
por: Myhr, Kirsten
Publicado: (2011) -
Big Pharma (The Play)
por: Bero, Lisa
Publicado: (2007) -
The Pharma-Nutritional Role of Antioxidant Phytochemicals in Health and Disease
por: Davinelli, Sergio, et al.
Publicado: (2022)